These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 31135297

  • 21. Resection margins and local recurrences of impalpable breast cancer: Comparison between radioguided occult lesion localization (ROLL) and radioactive seed localization (RSL).
    Niinikoski L, Hukkinen K, Leidenius MHK, Vaara P, Voynov A, Heikkilä P, Mattson J, Meretoja TJ.
    Breast; 2019 Oct; 47():93-101. PubMed ID: 31362135
    [Abstract] [Full Text] [Related]

  • 22. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
    Maeda H, Hayashida T, Watanuki R, Kikuchi M, Nakashoji A, Yokoe T, Seki T, Takahashi M, Kitagawa Y.
    Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
    [Abstract] [Full Text] [Related]

  • 23. Contrast-enhanced computed tomography for diagnosing the intraductal component and small invasive foci of breast cancer.
    Akashi-Tanaka S, Fukutomi T, Miyakawa K, Nanasawa T, Matsuo K, Hasegawa T, Tsuda H.
    Breast Cancer; 2001 Mar; 8(1):10-5. PubMed ID: 11180761
    [Abstract] [Full Text] [Related]

  • 24. Clinical application of a color map pattern on shear-wave elastography for invasive breast cancer.
    Lee S, Jung Y, Bae Y.
    Surg Oncol; 2016 Mar; 25(1):44-8. PubMed ID: 26979640
    [Abstract] [Full Text] [Related]

  • 25. Outcomes of Ductal Carcinoma In Situ According to Detection Modality: A Multicenter Study Comparing Recurrence Between Mammography and Breast US.
    Yoon JH, Han K, Koh J, Kim GR, Kim HJ, Park YM, Youk JH, Chung J, Chae IH, Choi EJ, Moon HJ.
    Ultrasound Med Biol; 2019 Oct; 45(10):2623-2633. PubMed ID: 31351671
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Diagnostic value of contrast-enhanced computed tomography for diagnosing the intraductal component of breast cancer.
    Akashi-Tanaka S, Fukutomi T, Miyakawa K, Uchiyama N, Tsuda H.
    Breast Cancer Res Treat; 1998 May; 49(1):79-86. PubMed ID: 9694614
    [Abstract] [Full Text] [Related]

  • 29. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography.
    Hata T, Takahashi H, Watanabe K, Takahashi M, Taguchi K, Itoh T, Todo S.
    J Am Coll Surg; 2004 Feb; 198(2):190-7. PubMed ID: 14759774
    [Abstract] [Full Text] [Related]

  • 30. Glandular Tissue Component and Breast Cancer Risk in Mammographically Dense Breasts at Screening Breast US.
    Lee SH, Ryu HS, Jang MJ, Yi A, Ha SM, Kim SY, Chang JM, Cho N, Moon WK.
    Radiology; 2021 Oct; 301(1):57-65. PubMed ID: 34282967
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S.
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [Abstract] [Full Text] [Related]

  • 33. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy.
    Jacquemier J, Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM.
    Br J Cancer; 1990 Jun; 61(6):873-6. PubMed ID: 2164836
    [Abstract] [Full Text] [Related]

  • 34. Association of mammography and ultrasound features with MammaPrint in patients with estrogen receptor-positive, HER2-negative, node-positive invasive breast cancer.
    Choi WJ, Sim H, Kim HJ, Cha JH, Shin HJ, Chae EY, Kim HH.
    Acta Radiol; 2021 Dec; 62(12):1592-1600. PubMed ID: 33302692
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Role of ultrasonography and MRI in the detection of wide intraductal component of invasive breast cancer--a prospective study.
    Sundararajan S, Tohno E, Kamma H, Ueno E, Minami M.
    Clin Radiol; 2007 Mar; 62(3):252-61. PubMed ID: 17293219
    [Abstract] [Full Text] [Related]

  • 37. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP, Ortiz-Perez T, Ebuoma LO, Sepulveda KA, Severs FJ, Roark A, Wang T, Sedgwick EL.
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [Abstract] [Full Text] [Related]

  • 38. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Chou SS, Romanoff J, Lehman CD, Khan SA, Carlos R, Badve SS, Xiao J, Corsetti RL, Javid SH, Spell DW, Han LK, Sabol JL, Bumberry JR, Gareen IF, Snyder BS, Gatsonis C, Wagner LI, Wolff AC, Miller KD, Sparano JA, Comstock CE, Rahbar H.
    Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.
    Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SL, Eberlein T, Love SM, Gelman R, Harris JR, Connolly JL.
    Cancer; 1996 Nov 01; 78(9):1921-8. PubMed ID: 8909312
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.